Back to Search
Start Over
Histopathological features of systemic sclerosis-associated myopathy: A scoping review
- Source :
- Autoimmunity Reviews. 20:102851
- Publication Year :
- 2021
- Publisher :
- Elsevier BV, 2021.
-
Abstract
- Background Scleromyositis (SM) is an emerging subset of myositis associated with features of systemic sclerosis (SSc) but it is currently not recognized as a distinct histopathological subset by the European NeuroMuscular Center (ENMC). Our aim was to review studies reporting muscle biopsies from SSc patients with myositis and to identify unique histopathological features of SM. Methods A scoping review was conducted and included all studies reporting histopathological findings in SSc patients with myositis searching the following databases: PubMed, MEDLINE, EMBASE, CINAHL and EBM-Reviews. Clinical, serological, and histopathological data were extracted using a standardized protocol. Results Out of 371 citations, 77 studies that included 559 muscle biopsies were extracted. Fifty-seven percent (n = 227/400) had inflammatory infiltrates, predominantly T cells, which were endomysial (49%), perimysial (42%) and perivascular (41%). Few studies (18%, n = 8/44) evaluated the presence of B-cells. Myofiber atrophy was present in 48% (n = 104/218) of biopsies, and was predominantly perifascicular in 19% (n = 6/31), with necrosis reported in 56% (n = 162/290) of cases. Sarcolemmal MHC-I upregulation was found in 72% (n = 64/89) of biopsies. Non-specified C5b-9 deposition was described in 39% of muscle biopsies (n = 28/72). Neurogenic features were present in 23% (n = 44/191); endomysial fibrosis was reported in 35% (n = 120/340); and rimmed vacuoles were observed in 32% (n = 11/34) of biopsies. Capillaropathy, such as capillary dropout and/or ultrastructural endothelial abnormalities, was reported in 33% (n = 43/129) of cases. Reported ENMC categories were mainly polymyositis (21%), non-specific myositis (19%), immune-mediated necrotizing myopathy (16%), and dermatomyositis (8%). Histopathological features were analyzed according to serological subtypes in 28 studies, including anti-PM-Scl (n = 48), -Ku (n = 23) and -U1RNP (n = 90). Most of these biopsies demonstrated inflammatory infiltrates (range 49–85%) as well as MHC-I expression (range 63–81%). Necrosis was associated with anti-Ku (85%) and anti-U1RNP (73%), while anti-Ku was also associated with neurogenic features and rimmed vacuoles in 57% and 25% of cases, respectively. Conclusion Our review suggests that SM is characterized by heterogeneous pathological features using definitions included in current histopathological criteria. Whether a distinct histopathological signature exists in SM remains to be determined. SSc-specific and SSc-associated autoantibodies may help define more homogeneous histopathological subsets.
- Subjects :
- 0301 basic medicine
Scleromyositis
Pathology
medicine.medical_specialty
Immunology
Polymyositis
03 medical and health sciences
0302 clinical medicine
Atrophy
Muscular Diseases
medicine
Humans
Immunology and Allergy
Myopathy
Pathological
Myositis
Autoantibodies
030203 arthritis & rheumatology
Scleroderma, Systemic
business.industry
Dermatomyositis
medicine.disease
030104 developmental biology
Histopathology
medicine.symptom
business
Subjects
Details
- ISSN :
- 15689972
- Volume :
- 20
- Database :
- OpenAIRE
- Journal :
- Autoimmunity Reviews
- Accession number :
- edsair.doi.dedup.....a75be4844b3ebd8bb01d1f87e988e81d
- Full Text :
- https://doi.org/10.1016/j.autrev.2021.102851